Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Clinical trial NCT01505114 · COMPLETED
Trial details
- NCT number
- NCT01505114
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.